Before You Invest in Sopan Pharmaceuticals Limited IPO, Take a Closer Look at the Company
Summary
Sopan Pharmaceuticals Limited, a Nepal-based allopathic medicine manufacturer, is issuing an IPO of 42.90 lakh shares at Rs. 100 to raise Rs. 42.90 crore, despite a low credit rating and recent earnings concerns.
Key Points
- Sopan Pharmaceuticals Limited is issuing 42.90 lakh shares at Rs. 100 each to raise Rs. 42.90 crore via IPO.
- The company holds manufacturing licenses for 116 medicines and sells 78 products across Nepal.
- Recent earnings per share dropped sharply from Rs. 18.33 to Rs. 0.70, raising concerns about profitability.
- The company has a CARE-NP B rating indicating a high risk of default, which investors should consider.
